P14. Cell-based gene delivery leverages conventional immunotherapy for cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P14. Cell-based gene delivery leverages conventional immunotherapy for cancer ; volume:2 ; number:2 ; day:12 ; month:3 ; year:2014 ; pages:1 ; date:3.2014
Journal for ImmunoTherapy of Cancer ; 2, Heft 2 (12.3.2014), 1, 3.2014
- Urheber
-
Günther, C.
- Beteiligte Personen und Organisationen
-
Huss, R.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-2-S2-P5
- URN
-
urn:nbn:de:1111-2016072657479
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Günther, C.
- Huss, R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
CD8+ T cell-based cancer immunotherapy
p16INK4a as target for T cell-based cancer immunotherapy
Targeting CD276 for T cell-based immunotherapy of breast cancer
Drug delivery methods for cancer immunotherapy
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
NK cell-based cancer immunotherapy: from basic biology to clinical development
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
Natural killer cell-based immunotherapy for acute myeloid leukemia
CD8+ T cell-based cancer immunotherapy
p16INK4a as target for T cell-based cancer immunotherapy
Targeting CD276 for T cell-based immunotherapy of breast cancer
Drug delivery methods for cancer immunotherapy
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
NK cell-based cancer immunotherapy: from basic biology to clinical development
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
Natural killer cell-based immunotherapy for acute myeloid leukemia
CD8+ T cell-based cancer immunotherapy
p16INK4a as target for T cell-based cancer immunotherapy
Targeting CD276 for T cell-based immunotherapy of breast cancer
Drug delivery methods for cancer immunotherapy
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
NK cell-based cancer immunotherapy: from basic biology to clinical development
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy